Heat stress proteins (HSP) regulate a variety of signaling pathways, including programmed cell death, neuroinflammation and immune response. Among all kinds of heat stress proteins, heat stress protein 70 (HSP70) has been studied most extensively, which can regulate stroke pathology by regulating brain damage, necroptosis, and blood-brain barrier permeability after stroke. Studies have shown that upregulation of HSP70 can effectively mitigate the damage caused by stroke. However, the research direction is more limited. Therefore, Ace Therapeutics offers comprehensive services to accelerate the development of stroke drugs targeting HSP70 protein.
Fig.1 Structure of heat shock protein 70.
HSP70 can regulate various activities of the body, including various activities of proteins, cell death, immunity, inflammation, oxidative stress and so on. It also plays an important role in the pathological process of stroke. The current study suggests that HSP70 can mitigate the harm of stroke by regulating the cell death process and enhancing anti-inflammatory capacity. Therefore, the effective screening of HSP70-targeting modulators is the first step in the development of stroke drugs targeting HSP70.
After screening and validating HSP70 modulators, Ace Therapeutics provides comprehensive services to further investigate the preclinical pharmacologic evaluation of modulators in stroke.
HSP70 can regulate a variety of pathological pathways and affect the pathological process of stroke. Therefore, the development of stroke drugs targeting HSP70 is an effective way to treat stroke. If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.